These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 21909806)

  • 41. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction.
    Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M
    Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical outcomes of patients with diabetic nephropathy randomized to clopidogrel plus aspirin versus aspirin alone (a post hoc analysis of the clopidogrel for high atherothrombotic risk and ischemic stabilization, management, and avoidance [CHARISMA] trial).
    Dasgupta A; Steinhubl SR; Bhatt DL; Berger PB; Shao M; Mak KH; Fox KA; Montalescot G; Weber MA; Haffner SM; Dimas AP; Steg PG; Topol EJ;
    Am J Cardiol; 2009 May; 103(10):1359-63. PubMed ID: 19427428
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of clopidogrel and aspirin combination versus aspirin alone on platelet aggregation and major receptor expression in patients with heart failure: the Plavix Use for Treatment Of Congestive Heart Failure (PLUTO-CHF) trial.
    Serebruany VL; Malinin AI; Jerome SD; Lowry DR; Morgan AW; Sane DC; Tanguay JF; Steinhubl SR; O'connor CM
    Am Heart J; 2003 Oct; 146(4):713-20. PubMed ID: 14564328
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of antiplatelet and anticoagulant therapy on the clinical outcome of patients undergoing ureteroscopy.
    Toepfer NJ; Baylor K; Henry Y; Simmons J; Berger PB
    Urology; 2013 Oct; 82(4):773-9. PubMed ID: 23876586
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [SECONDARY PREVENTION IN PATIENTS WITH ACUTE CORONARY SYNDROME HOSPITALIZED IN INTERNAL MEDICINE DEPARTMENTS].
    Yahia DH; Pereg D; Lishner M; Elis A
    Harefuah; 2015 May; 154(5):299-302, 339-40. PubMed ID: 26168639
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.
    Coleman CI; Straznitskas AD; Sobieraj DM; Kluger J; Anglade MW
    Am J Cardiol; 2012 Apr; 109(7):1020-5. PubMed ID: 22221944
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Early treatment for non-ST-segment elevation acute coronary syndrome is associated with appropriate discharge care.
    Fermann GJ; Raja AS; Peterson ED; Roe MT; Hoekstra JW; Milford-Beland S; Diercks DB; Pollack CV; Peacock WF; Summers R; Ohman EM; Gibler WB
    Clin Cardiol; 2009 Sep; 32(9):519-25. PubMed ID: 19743495
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS; Bajorek BV
    J Clin Pharm Ther; 2008 Dec; 33(6):591-601. PubMed ID: 19138236
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Benefit of warfarin compared with aspirin in patients with heart failure in sinus rhythm: a subgroup analysis of WARCEF, a randomized controlled trial.
    Homma S; Thompson JL; Sanford AR; Mann DL; Sacco RL; Levin B; Pullicino PM; Freudenberger RS; Teerlink JR; Graham S; Mohr JP; Massie BM; Labovitz AJ; Di Tullio MR; Gabriel AP; Lip GY; Estol CJ; Lok DJ; Ponikowski P; Anker SD;
    Circ Heart Fail; 2013 Sep; 6(5):988-97. PubMed ID: 23881846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of coadministration of aspirin or clopidogrel on exercise testing in patients with heart failure receiving angiotensin-converting enzyme inhibitors.
    Kindsvater S; Leclerc K; Ward J
    Am J Cardiol; 2003 Jun; 91(11):1350-2. PubMed ID: 12767432
    [No Abstract]   [Full Text] [Related]  

  • 51. Duration of dual antiplatelet treatment with clopidogrel and aspirin in patients with acute coronary syndrome.
    Varenhorst C; Jensevik K; Jernberg T; Sundström A; Hasvold P; Held C; Lagerqvist B; James S
    Eur Heart J; 2014 Apr; 35(15):969-78. PubMed ID: 24122961
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Warfarin use in nursing home residents: results from the 2004 national nursing home survey.
    Ghaswalla PK; Harpe SE; Slattum PW
    Am J Geriatr Pharmacother; 2012 Feb; 10(1):25-36.e2. PubMed ID: 22226690
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Edoxaban versus placebo, aspirin, or aspirin plus clopidogrel for stroke prevention in atrial fibrillation. An indirect comparison analysis.
    Blann AD; Skjøth F; Rasmussen LH; Larsen TB; Lip GY
    Thromb Haemost; 2015 Aug; 114(2):403-9. PubMed ID: 26062437
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison between zofenopril and ramipril in combination with acetylsalicylic acid in patients with left ventricular systolic dysfunction after acute myocardial infarction: results of a randomized, double-blind, parallel-group, multicenter, European study (SMILE-4).
    Borghi C; Ambrosioni E; Novo S; Vinereanu D; Ambrosio G;
    Clin Cardiol; 2012; 35(7):416-23. PubMed ID: 22707187
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
    Rubboli A; Halperin JL
    Thromb Haemost; 2008 Nov; 100(5):752-3. PubMed ID: 18989515
    [No Abstract]   [Full Text] [Related]  

  • 56. Clopidogrel discontinuation after acute coronary syndromes: frequency, predictors and associations with death and myocardial infarction--a hospital registry-primary care linked cohort (MINAP-GPRD).
    Boggon R; van Staa TP; Timmis A; Hemingway H; Ray KK; Begg A; Emmas C; Fox KA
    Eur Heart J; 2011 Oct; 32(19):2376-86. PubMed ID: 21875855
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Contra: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regimen in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'. Not for everybody.
    Roldán V; Marín F
    Thromb Haemost; 2008 Nov; 100(5):754-5. PubMed ID: 18989516
    [No Abstract]   [Full Text] [Related]  

  • 58. Antiplatelet effects of angiotensin-converting enzyme inhibitors compared with aspirin and clopidogrel: a pilot study with whole-blood aggregometry.
    Bauriedel G; Skowasch D; Schneider M; Andrié R; Jabs A; Lüderitz B
    Am Heart J; 2003 Feb; 145(2):343-8. PubMed ID: 12595854
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of clopidogrel (Plavix) and other oral anticoagulants on early hip fracture surgery.
    Collinge CA; Kelly KC; Little B; Weaver T; Schuster RD
    J Orthop Trauma; 2012 Oct; 26(10):568-73. PubMed ID: 22441640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The role of warfarin and aspirin in secondary prevention of stroke.
    Elkind MS
    Curr Cardiol Rep; 2004 Mar; 6(2):135-42. PubMed ID: 14759359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.